Alle Meije Wink - Publications

Affiliations: 
VU University Medical Center, Amsterdam, Netherlands 
Area:
Neuroimaging, Image analysis, Signal processing

65 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Lorenzini L, Maranzano A, Ingala S, Collij LE, Tranfa M, Blennow K, Di Perri C, Foley C, Fox NC, Frisoni GB, Haller S, Martinez-Lage P, Mollison D, O'Brien J, Payoux P, ... ... Wink AM, et al. Association of Vascular Risk Factors and Cerebrovascular Pathology With Alzheimer Disease Pathologic Changes in Individuals Without Dementia. Neurology. 103: e209801. PMID 39288341 DOI: 10.1212/WNL.0000000000209801  0.358
2024 Lorenzini L, Collij LE, Tesi N, Vilor-Tejedor N, Ingala S, Blennow K, Foley C, Frisoni GB, Haller S, Holstege H, van der van der Lee S, Martinez-Lage P, Marioni RE, McCartney DL, O' Brien J, ... ... Wink AM, et al. Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non-demented individuals. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 39073684 DOI: 10.1002/alz.14096  0.344
2024 Mastenbroek SE, Sala A, Vállez García D, Shekari M, Salvadó G, Lorenzini L, Pieperhoff L, Wink AM, Lopes Alves I, Wolz R, Ritchie C, Boada M, Visser PJ, Bucci M, Farrar G, et al. Continuous β-Amyloid CSF/PET Imbalance Model to Capture Alzheimer Disease Heterogeneity. Neurology. 103: e209419. PMID 38862136 DOI: 10.1212/WNL.0000000000209419  0.337
2024 Tranfa M, Lorenzini L, Collij LE, Vállez García D, Ingala S, Pontillo G, Pieperhoff L, Maranzano A, Wolz R, Haller S, Blennow K, Frisoni G, Sudre CH, Chételat G, Ewers M, ... ... Wink AM, et al. Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure. Annals of Clinical and Translational Neurology. PMID 38757392 DOI: 10.1002/acn3.52071  0.383
2023 Bollack A, Markiewicz PJ, Wink AM, Prosser L, Lilja J, Bourgeat P, Schott JM, Coath W, Collij LE, Pemberton HG, Farrar G, Barkhof F, Cash DM. Evaluation of novel data-driven metrics of amyloid β deposition for longitudinal PET studies. Neuroimage. 120313. PMID 37595816 DOI: 10.1016/j.neuroimage.2023.120313  0.301
2023 Lorenzini L, Ingala S, Collij LE, Wottschel V, Haller S, Blennow K, Frisoni G, Chételat G, Payoux P, Lage-Martinez P, Ewers M, Waldman A, Wardlaw J, Ritchie C, Gispert JD, ... ... Wink AM, et al. Eigenvector centrality dynamics are related to Alzheimer's disease pathological changes in non-demented individuals. Brain Communications. 5: fcad088. PMID 37151225 DOI: 10.1093/braincomms/fcad088  0.432
2023 Dijsselhof MBJ, Barboure M, Stritt M, Nordhøy W, Wink AM, Beck D, Westlye LT, Cole JH, Barkhof F, Mutsaerts HJMM, Petr J. The value of arterial spin labelling perfusion MRI in brain age prediction. Human Brain Mapping. PMID 36852443 DOI: 10.1002/hbm.26242  0.318
2022 Lorenzini L, Ingala S, Wink AM, Kuijer JPA, Wottschel V, Dijsselhof M, Sudre CH, Haller S, Molinuevo JL, Gispert JD, Cash DM, Thomas DL, Vos SB, Prados F, Petr J, et al. The Open-Access European Prevention of Alzheimer's Dementia (EPAD) MRI dataset and processing workflow. Neuroimage. Clinical. 35: 103106. PMID 35839659 DOI: 10.1016/j.nicl.2022.103106  0.391
2022 Lorenzini L, Ansems LT, Lopes Alves I, Ingala S, Vállez García D, Tomassen J, Sudre C, Salvadó G, Shekari M, Operto G, Brugulat-Serrat A, Sánchez-Benavides G, Ten Kate M, Tijms B, Wink AM, et al. Regional associations of white matter hyperintensities and early cortical amyloid pathology. Brain Communications. 4: fcac150. PMID 35783557 DOI: 10.1093/braincomms/fcac150  0.409
2022 Collij LE, Salvadó G, Wottschel V, Mastenbroek SE, Schoenmakers P, Heeman F, Aksman L, Wink AM, Berckel BNM, van de Flier WM, Scheltens P, Visser PJ, Barkhof F, Haller S, Gispert JD, et al. Spatial-Temporal Patterns of Amyloid-β Accumulation: A Subtype and Stage Inference Model Analysis. Neurology. PMID 35292558 DOI: 10.1212/WNL.0000000000200148  0.302
2021 Ingala S, Tomassen J, Collij LE, Prent N, van 't Ent D, Ten Kate M, Konijnenberg E, Yaqub M, Scheltens P, de Geus EJC, Teunissen CE, Tijms B, Wink AM, Barkhof F, van Berckel BNM, et al. Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals. Brain Communications. 3: fcab201. PMID 34617016 DOI: 10.1093/braincomms/fcab201  0.376
2021 Collij LE, Mastenbroek SE, Salvadó G, Wink AM, Visser PJ, Barkhof F, van Berckel BNM, Lopes Alves I. Regional amyloid accumulation predicts memory decline in initially cognitively unimpaired individuals. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12216. PMID 34368416 DOI: 10.1002/dad2.12216  0.351
2021 Huiskamp M, Eijlers AJC, Broeders TAA, Pasteuning J, Dekker I, Uitdehaag BMJ, Barkhof F, Wink AM, Geurts JJG, Hulst HE, Schoonheim MM. Longitudinal Network Changes and Conversion to Cognitive Impairment in Multiple Sclerosis. Neurology. PMID 34099528 DOI: 10.1212/WNL.0000000000012341  0.354
2021 Collij LE, Ingala S, Top H, Wottschel V, Stickney KE, Tomassen J, Konijnenberg E, Ten Kate M, Sudre C, Lopes Alves I, Yaqub MM, Wink AM, Van 't Ent D, Scheltens P, van Berckel BNM, et al. White matter microstructure disruption in early stage amyloid pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12124. PMID 33816751 DOI: 10.1002/dad2.12124  0.38
2021 Ingala S, De Boer C, Masselink LA, Vergari I, Lorenzini L, Blennow K, Chételat G, Di Perri C, Ewers M, van der Flier WM, Fox NC, Gispert JD, Haller S, Molinuevo JL, Muniz-Terrera G, ... ... Wink AM, et al. Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33811742 DOI: 10.1002/alz.12292  0.329
2021 Collij LE, Salvadó G, Shekari M, Alves IL, Reimand J, Wink AM, Zwan M, Niñerola-Baizán A, Perissinotti A, Scheltens P, Ikonomovic MD, Smith APL, Farrar G, Molinuevo JL, Barkhof F, et al. Visual assessment of [F]flutemetamol PET images can detect early amyloid pathology and grade its extent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33615397 DOI: 10.1007/s00259-020-05174-2  0.3
2021 Chard DT, Alahmadi AAS, Audoin B, Charalambous T, Enzinger C, Hulst HE, Rocca MA, Rovira À, Sastre-Garriga J, Schoonheim MM, Tijms B, Tur C, Gandini Wheeler-Kingshott CAM, Wink AM, Ciccarelli O, et al. Mind the gap: from neurons to networks to outcomes in multiple sclerosis. Nature Reviews. Neurology. PMID 33437067 DOI: 10.1038/s41582-020-00439-8  0.333
2020 Dekker I, Schoonheim MM, Venkatraghavan V, Eijlers AJC, Brouwer I, Bron EE, Klein S, Wattjes MP, Wink AM, Geurts JJG, Uitdehaag BMJ, Oxtoby NP, Alexander DC, Vrenken H, Killestein J, et al. The sequence of structural, functional and cognitive changes in multiple sclerosis. Neuroimage. Clinical. 29: 102550. PMID 33418173 DOI: 10.1016/j.nicl.2020.102550  0.322
2020 Mutsaerts HJMM, Petr J, Groot P, Vandemaele P, Ingala S, Robertson AD, Václavů L, Groote I, Kuijf H, Zelaya F, O'Daly O, Hilal S, Wink AM, Kant I, Caan MWA, et al. ExploreASL: an image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 117031. PMID 32526385 DOI: 10.1016/J.Neuroimage.2020.117031  0.341
2020 Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, et al. Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32281303 DOI: 10.1002/Alz.12069  0.367
2019 van Loenhoud AC, van der Flier WM, Wink AM, Dicks E, Groot C, Twisk J, Barkhof F, Scheltens P, Ossenkoppele R. Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship. Neurology. PMID 31266904 DOI: 10.1212/Wnl.0000000000007821  0.366
2018 Collij L, Konijnenberg E, Reimand J, Ten Kate M, Den Braber A, Lopes Alves I, Zwan M, Yaqub M, Van Assema D, Wink AM, Lammertsma A, Scheltens P, Visser PJ, Barkhof F, Van Berckel B. Assessing Amyloid Pathology in Cognitively Normal Subjects using [F]Flutemetamol PET: Comparing Visual Reads and Quantitative Methods. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30315145 DOI: 10.2967/Jnumed.118.211532  0.349
2018 Wink AM, Tijms BM, Ten Kate M, Raspor E, de Munck JC, Altena E, Ecay-Torres M, Clerigue M, Estanga A, Garcia-Sebastian M, Izagirre A, Martinez-Lage Alvarez P, Villanua J, Barkhof F, Sanz-Arigita E. Functional brain network centrality is related to APOE genotype in cognitively normal elderly. Brain and Behavior. e01080. PMID 30136422 DOI: 10.1002/Brb3.1080  0.411
2018 Bouts MJRJ, Möller C, Hafkemeijer A, van Swieten JC, Dopper E, van der Flier WM, Vrenken H, Wink AM, Pijnenburg YAL, Scheltens P, Barkhof F, Schouten TM, de Vos F, Feis RA, van der Grond J, et al. Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging. Journal of Alzheimer's Disease : Jad. PMID 29614652 DOI: 10.3233/Jad-170893  0.394
2017 van Loenhoud AC, Wink AM, Groot C, Verfaillie SCJ, Twisk J, Barkhof F, van Berckel B, Scheltens P, van der Flier WM, Ossenkoppele R. A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease. Human Brain Mapping. PMID 28631336 DOI: 10.1002/Hbm.23695  0.417
2017 van Duinkerken E, Schoonheim MM, IJzerman RG, Moll AC, Landeira-Fernandez J, Klein M, Diamant M, Snoek FJ, Barkhof F, Wink AM. Altered eigenvector centrality is related to local resting-state network functional connectivity in patients with longstanding type 1 diabetes mellitus. Human Brain Mapping. PMID 28429383 DOI: 10.1002/Hbm.23617  0.346
2017 Eijlers AJ, Meijer KA, Wassenaar TM, Steenwijk MD, Uitdehaag BM, Barkhof F, Wink AM, Geurts JJ, Schoonheim MM. Increased default-mode network centrality in cognitively impaired multiple sclerosis patients. Neurology. PMID 28179464 DOI: 10.1212/Wnl.0000000000003689  0.345
2017 van Loenhoud AC, van der Flier WM, Wink AM, Groot C, Twisk JW, van Berckel BN, Barkhof F, Scheltens P, Ossenkoppele R. PREDICTING PROGRESSION IN PRE-DEMENTIA STAGES OF ALZHEIMER’S DISEASE WITH A NEUROIMAGING MEASURE OF COGNITIVE RESERVE Alzheimer's & Dementia. 13: P581-P582. DOI: 10.1016/J.Jalz.2017.07.206  0.345
2017 Wottschel V, Wink AM, Tijms BM, Collij L, Kuijer J, van der Flier WM, Scheltens P, Barkhof F. [P1-392]: AUTOMATED SELECTION OF MULTIMODAL MRI BIOMARKERS FOR DIAGNOSIS OF DEMENTIA Alzheimer's & Dementia. 13: P417-P418. DOI: 10.1016/J.Jalz.2017.06.408  0.397
2016 Collij LE, Heeman F, Kuijer JP, Ossenkoppele R, Benedictus MR, Möller C, Verfaillie SC, Sanz-Arigita EJ, van Berckel BN, van der Flier WM, Scheltens P, Barkhof F, Wink AM. Application of Machine Learning to Arterial Spin Labeling in Mild Cognitive Impairment and Alzheimer Disease. Radiology. 152703. PMID 27383395 DOI: 10.1148/Radiol.2016152703  0.385
2016 Ten Kate M, Sanz-Arigita EJ, Tijms BM, Wink AM, Clerigue M, Garcia-Sebastian M, Izagirre A, Ecay-Torres M, Estanga A, Villanua J, Vrenken H, Visser PJ, Martinez-Lage P, Barkhof F. Impact of APOE-ɛ4 and family history of dementia on gray matter atrophy in cognitively healthy middle-aged adults. Neurobiology of Aging. 38: 14-20. PMID 26827639 DOI: 10.1016/J.Jalz.2015.06.130  0.382
2016 van Loenhoud AC, Wink AM, Groot C, Verfaillie SC, Barkhof F, van Berckel BN, Scheltens P, van der Flier WM, Ossenkoppele R. P4-191: A Novel Neuroimaging Approach to Capture Cognitive Reserve Alzheimer's & Dementia. 12: P1095-P1096. DOI: 10.1016/J.Jalz.2016.06.2283  0.31
2015 Möller C, Pijnenburg YA, van der Flier WM, Versteeg A, Tijms B, de Munck JC, Hafkemeijer A, Rombouts SA, van der Grond J, van Swieten J, Dopper E, Scheltens P, Barkhof F, Vrenken H, Wink AM. Alzheimer Disease and Behavioral Variant Frontotemporal Dementia: Automatic Classification Based on Cortical Atrophy for Single-Subject Diagnosis. Radiology. 150220. PMID 26653846 DOI: 10.1148/Radiol.2015150220  0.373
2015 Steenwijk MD, Geurts JJ, Daams M, Tijms BM, Wink AM, Balk LJ, Tewarie PK, Uitdehaag BM, Barkhof F, Vrenken H, Pouwels PJ. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Brain : a Journal of Neurology. PMID 26637488 DOI: 10.1093/Brain/Awv337  0.347
2015 Tijms BM, Kate MT, Wink AM, Visser PJ, Ecay M, Clerigue M, Estanga A, Garcia Sebastian M, Izagirre A, Villanua J, Martinez Lage P, van der Flier WM, Scheltens P, Sanz Arigita E, Barkhof F. Gray matter network disruptions and amyloid beta in cognitively normal adults. Neurobiology of Aging. PMID 26559882 DOI: 10.1016/J.Neurobiolaging.2015.10.015  0.421
2015 Adriaanse SM, Wink AM, Tijms BM, Ossenkoppele R, Verfaillie S, Lammertsma AA, Boellaard R, Scheltens P, van Berckel BN, Barkhof F. The association of glucose metabolism and eigenvector centrality in Alzheimer's disease. Brain Connectivity. PMID 26414628 DOI: 10.1089/Brain.2014.0320  0.344
2015 Schoonheim MM, Hulst HE, Brandt RB, Strik M, Wink AM, Uitdehaag BM, Barkhof F, Geurts JJ. Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis. Neurology. 84: 776-83. PMID 25616483 DOI: 10.1212/Wnl.0000000000001285  0.347
2015 Tijms BM, Kate M, Wink AM, Visser PJ, Ecay M, Estanga A, Clerigue M, Garcia-Sebastian M, Izagirre A, Villanua J, Martinez-Lage P, van der Flier WM, Scheltens P, Sanz-Arigita E, Barkhof F. P3-158: Grey matter network disruptions are related to amyloid beta in cognitively healthy elderly Alzheimer's & Dementia. 11: P689-P689. DOI: 10.1016/j.jalz.2015.06.1529  0.351
2015 Wink AM, Verfaillie S, Adriaanse S, Benedictus M, Kuijer J, de Munck J, Wattjes M, van der Flier WM, Scheltens P, van Berckel BN, Barkhof F. IC-P-124: Classification of resting-state cerebral perfusion maps from patients with Alzheimer's disease and patients with frontotemporal dementia Alzheimer's & Dementia. 11: P85-P85. DOI: 10.1016/J.Jalz.2015.06.146  0.328
2015 Tijms BM, Wink AM, Kate M, Visser PJ, Ecay M, Izagirre A, Estanga A, Clerigue M, Garcia-Sebastian M, Villanua J, Martinez-Lage P, van der Flier WM, Scheltens P, Sanz-Arigita E, Barkhof F. IC-04-03: Grey matter network disruptions are related to amyloid-beta in cognitively healthy elderly Alzheimer's & Dementia. 11: P11-P11. DOI: 10.1016/J.Jalz.2015.06.017  0.338
2014 Adriaanse SM, Binnewijzend MA, Ossenkoppele R, Tijms BM, van der Flier WM, Koene T, Smits LL, Wink AM, Scheltens P, van Berckel BN, Barkhof F. Widespread disruption of functional brain organization in early-onset Alzheimer's disease. Plos One. 9: e102995. PMID 25080229 DOI: 10.1371/Journal.Pone.0102995  0.416
2014 Veijola J, Guo JY, Moilanen JS, Jääskeläinen E, Miettunen J, Kyllönen M, Haapea M, Huhtaniska S, Alaräisänen A, Mäki P, Kiviniemi V, Nikkinen J, Starck T, Remes JJ, Tanskanen P, ... ... Wink AM, et al. Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication. Plos One. 9: e101689. PMID 25036617 DOI: 10.1371/Journal.Pone.0101689  0.426
2014 Binnewijzend MA, Adriaanse SM, Van der Flier WM, Teunissen CE, de Munck JC, Stam CJ, Scheltens P, van Berckel BN, Barkhof F, Wink AM. Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and CSF biomarkers. Human Brain Mapping. 35: 2383-93. PMID 24039033 DOI: 10.1016/J.Jalz.2013.05.059  0.466
2014 Adriaanse SM, Sanz-Arigita EJ, Binnewijzend MA, Ossenkoppele R, Tolboom N, van Assema DM, Wink AM, Boellaard R, Yaqub M, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Rombouts SA, Barkhof F, et al. Amyloid and its association with default network integrity in Alzheimer's disease. Human Brain Mapping. 35: 779-91. PMID 23238869 DOI: 10.1002/Hbm.22213  0.422
2014 Tijms BM, Wink AM, Binnewijzend M, Adriaanse S, Van der Flier WM, Stam C, Scheltens P, Barkhof F. P1-233: MULTIMODAL BRAIN NETWORK ALTERATIONS IN ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT PATIENTS Alzheimer's & Dementia. 10: P389-P390. DOI: 10.1016/J.Jalz.2014.05.472  0.405
2013 Schoonheim M, Geurts J, Wiebenga O, De Munck J, Polman C, Stam C, Barkhof F, Wink A. Changes in functional network centrality underlie cognitive dysfunction and physical disability in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1058-1065. PMID 24347184 DOI: 10.1177/1352458513516892  0.324
2013 Tijms BM, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F. Alzheimer's disease: connecting findings from graph theoretical studies of brain networks. Neurobiology of Aging. 34: 2023-36. PMID 23541878 DOI: 10.1016/J.Neurobiolaging.2013.02.020  0.341
2013 Tijms BM, Möller C, Vrenken H, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F. Single-subject grey matter graphs in Alzheimer's disease. Plos One. 8: e58921. PMID 23536835 DOI: 10.1371/Journal.Pone.0058921  0.416
2013 Binnewijzend MA, Kuijer JP, Benedictus MR, van der Flier WM, Wink AM, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology. 267: 221-30. PMID 23238159 DOI: 10.1148/Radiol.12120928  0.416
2013 Tijms BM, Möller C, Vrenken H, Wink AM, de Haan W, van der Flier WM, Stam CJ, Scheltens P, Barkhof F. Correction: Single-Subject Grey Matter Graphs in Alzheimer's Disease Plos One. 8. DOI: 10.1371/Annotation/6A2E6405-Ce1D-49E0-A88C-0017C680D597  0.314
2013 Tijms B, Möller C, Vrenken H, Wink AM, de Haan W, Van der Flier W, Stam C, Scheltens P, Barkhof F. P1-287: Grey matter graph properties are related to disease severity in Alzheimer's disease Alzheimer's & Dementia. 9: P259-P259. DOI: 10.1016/J.Jalz.2013.05.512  0.318
2013 Binnewijzend M, Adriaanse S, Van der Flier W, Teunissen C, De Munck J, Stam C, Scheltens P, van Berckel B, Barkhof F, Wink AM. O4-03-02: Brain network alterations in Alzheimer's disease measured by eigenvector centrality in fMRI are related to cognition and cerebrospinal fluid biomarkers Alzheimer's & Dementia. 9: P684-P684. DOI: 10.1016/J.Jalz.2013.04.347  0.386
2012 Wink AM, de Munck JC, van der Werf YD, van den Heuvel OA, Barkhof F. Fast eigenvector centrality mapping of voxel-wise connectivity in functional magnetic resonance imaging: implementation, validation, and interpretation. Brain Connectivity. 2: 265-74. PMID 23016836 DOI: 10.1089/Brain.2012.0087  0.385
2012 Binnewijzend MA, Schoonheim MM, Sanz-Arigita E, Wink AM, van der Flier WM, Tolboom N, Adriaanse SM, Damoiseaux JS, Scheltens P, van Berckel BN, Barkhof F. Resting-state fMRI changes in Alzheimer's disease and mild cognitive impairment. Neurobiology of Aging. 33: 2018-28. PMID 21862179 DOI: 10.1016/J.Neurobiolaging.2011.07.003  0.447
2012 de Bie HM, Boersma M, Adriaanse S, Veltman DJ, Wink AM, Roosendaal SD, Barkhof F, Stam CJ, Oostrom KJ, Delemarre-van de Waal HA, Sanz-Arigita EJ. Resting-state networks in awake five- to eight-year old children. Human Brain Mapping. 33: 1189-201. PMID 21520347 DOI: 10.1002/Hbm.21280  0.375
2011 Wink AM, Binnewijzend M, van Berckel BN, Barkhof F. P1-362: Fractal differences in MRI time series between Alzheimer's disease patients and controls Alzheimer's & Dementia. 7: S229-S229. DOI: 10.1016/J.Jalz.2011.05.642  0.35
2009 Ooi C, Bullmore ET, Wink AM, Sendur L, Barnes A, Achard S, Aspden J, Abbott S, Yue S, Kitzbichler M, Meunier D, Maxim V, Salvador R, Henty J, Tait R, et al. CamBAfx: Workflow Design, Implementation and Application for Neuroimaging. Frontiers in Neuroinformatics. 3: 27. PMID 19826470 DOI: 10.3389/Neuro.11.027.2009  0.643
2008 Suckling J, Wink AM, Bernard FA, Barnes A, Bullmore E. Endogenous multifractal brain dynamics are modulated by age, cholinergic blockade and cognitive performance. Journal of Neuroscience Methods. 174: 292-300. PMID 18703089 DOI: 10.1016/J.Jneumeth.2008.06.037  0.551
2008 Wink AM, Bullmore E, Barnes A, Bernard F, Suckling J. Monofractal and multifractal dynamics of low frequency endogenous brain oscillations in functional MRI. Human Brain Mapping. 29: 791-801. PMID 18465788 DOI: 10.1002/Hbm.20593  0.575
2008 Wink AM, Hoogduin H, Roerdink JB. Data-driven haemodynamic response function extraction using Fourier-wavelet regularised deconvolution. Bmc Medical Imaging. 8: 7. PMID 18402674 DOI: 10.1186/1471-2342-8-7  0.617
2008 Barnes A, Honey G, Wink AM, Bullmore ET, Suckling J. Modulation of the fractal properties of low frequency endogenous brain oscillations in functional MRI by a working memory task Proceedings of the International Joint Conference On Neural Networks. 3762-3765. DOI: 10.1109/IJCNN.2008.4634338  0.51
2006 Wink AM, Roerdink JB. BOLD Noise Assumptions in fMRI. International Journal of Biomedical Imaging. 2006: 12014. PMID 23165015 DOI: 10.1155/IJBI/2006/12014  0.6
2006 Suckling J, Davis MH, Ooi C, Wink AM, Fadili J, Salvador R, Welchew D, Sendur L, Maxim V, Bullmore ET. Permutation testing of orthogonal factorial effects in a language-processing experiment using fMRI. Human Brain Mapping. 27: 425-33. PMID 16596618 DOI: 10.1002/Hbm.20252  0.549
2006 Wink AM, Bernard F, Salvador R, Bullmore E, Suckling J. Age and cholinergic effects on hemodynamics and functional coherence of human hippocampus. Neurobiology of Aging. 27: 1395-404. PMID 16202481 DOI: 10.1016/J.Neurobiolaging.2005.08.011  0.526
2004 Wink AM, Roerdink JB. Denoising functional MR images: a comparison of wavelet denoising and Gaussian smoothing. Ieee Transactions On Medical Imaging. 23: 374-87. PMID 15027530 DOI: 10.1109/TMI.2004.824234  0.617
Show low-probability matches.